It’s time for <a href='https://research.berenberg.com/report/CE427A090B3EA4B4C8C63EB3B8C44FF4'>Top of the Pills 2026</a>! Kerry and Luisa discuss their analysis of the top 50 drugs by NPV from Berenberg DrugBank. The team also highlight their “Annual check-up” series, detailing key findings from pharma annual reports, including <a href='https://research.berenberg.com/report/BE435533604B290A1F3E1E94B8CE2B88'>AstraZeneca</a>, <a href='https://research.berenberg.com/report/1887B07316B9161692D54FCDBBD41E46'>AbbVie</a>, <a href='https://research.berenberg.com/report/30F60D000FF5E207BADBE29941B2A23B'>UCB</a> and <a href='https://research.berenberg.com/report/35144C4199D94F452A36141177F13B51'>Pfizer</a>.

It’s time for Top of the Pills 2026! Kerry and Luisa discuss their analysis of the top 50 drugs by NPV from Berenberg DrugBank. The team also highlight their “Annual check-up” series, detailing key findings from pharma annual reports, including AstraZeneca, AbbVie, UCB and Pfizer.

It’s time for <a href="https://research.berenberg.com/report/CE427A090B3EA4B4C8C63EB3B8C44FF4" rel="noopener noreferrer">Top of the Pills 2026</a>! Kerry and Luisa discuss their analysis of the top 50 drugs by NPV from Berenberg DrugBank. The team also highlight their “Annual check-up” series, detailing key findings from pharma annual reports, including <a href="https://research.berenberg.com/report/BE435533604B290A1F3E1E94B8CE2B88" rel="noopener noreferrer">AstraZeneca</a>, <a href="https://research.berenberg.com/report/1887B07316B9161692D54FCDBBD41E46" rel="noopener noreferrer">AbbVie</a>, <a href="https://research.berenberg.com/report/30F60D000FF5E207BADBE29941B2A23B" rel="noopener noreferrer">UCB</a> and <a href="https://research.berenberg.com/report/35144C4199D94F452A36141177F13B51" rel="noopener noreferrer">Pfizer</a>.&nbsp;

Episode 7

Welcome to “Over the Pill”, the Berenberg podcast where Kerry Holford &amp; Luisa Hector lift the curtain on the messy reality of analysing pharma share prices. With over 30 years of friendship, Kerry &amp; Luisa invite listeners into their regular debates on pharma strategy, drug pipeline prospects and commercial power.&nbsp;

Business

Welcome to “Over the Pill”, the Berenberg podcast where Kerry Holford & Luisa Hector lift the curtain on the messy reality of analysing pharma share prices. With over 30 years of friendship, Kerry & Luisa invite listeners into their regular debates on pharma strategy, drug pipeline prospects and commercial power. 

Share Episode 7

Sign up to save your podcasts

Episode 7

Episode 7